Supplementary Table S5 from Adaptive Responses to Dasatinib-Treated Lung Squamous Cell Cancer Cells Harboring DDR2 Mutations
crossref（2023）
摘要
Supplementary Table S5. Bliss analysis summary of drug combinations with dasatinib in DDR2-mutant squamous cell carcinoma cells.
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要